| Name: | Allopurinol Riboside |
| Catalogue No. | VL1430009 |
| CAS No. | 16220-07-8 |
| Molecular Formula | C10H12N4O5 |
| Molecular Weight | 268.23 g/mol |
| Status | In-Stock |
| IUPAC Name | 1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4-one |
| Description | Allopurinol Riboside (CAS No: 16220-07-8) or 1-β-D-Ribofuranosyl-1H-pyrazolo[3,4-d]pyrimidine-4-one is a structural analogue of inosine that is active in vitro against a variety of species of Leishmania and Trypanosoma that is used in the treatment of American cutaneous leishmaniasis. |
| References | Saenz, R. E., et al. “Treatment of American Cutaneous Leishmaniasis with Orally Administered Allopurinol Riboside.” Journal of Infectious Diseases, vol. 160, no. 1, July 1989, pp. 153–58,https://doi.org/10.1093/infdis/160.1.153. |
